| Drug Name | Enfuvirtide |
|---|---|
| Description | Enfuvirtide is a 36 residue synthetic peptide that inhibits HIV-1 fusion with CD4 cells. It is an N-terminal acetylated, C-terminal amide. As an HIV fusion inhibitor, it is the first of a novel class of antiretroviral drugs used in combination therapy for |
| Target | Envelope glycoprotein |
| ATC | J05AX07 |
| Indication | Enfuvirtide is an antiretroviral drug used in combination therapy for the treatment of HIV-1/AIDS. |
Extended Information